K, H., S, M., E, B., W, S., J, O., S, H., . . . Y, K. (2026). Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer. Cancer medicine, 15(1), e71548. https://doi.org/10.1002/cam4.71548
Chicago Style (17th ed.) CitationK, Ho, et al. "Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer." Cancer Medicine 15, no. 1 (2026): e71548. https://doi.org/10.1002/cam4.71548.
MLA (9th ed.) CitationK, Ho, et al. "Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal Cancer." Cancer Medicine, vol. 15, no. 1, 2026, p. e71548, https://doi.org/10.1002/cam4.71548.